表紙
市場調査レポート

動脈瘤性くも膜下出血:世界の治験レビュー

Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, H1, 2014

発行 GlobalData 商品コード 226832
出版日 ページ情報 英文 75 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.02円で換算しております。
Back to Top
動脈瘤性くも膜下出血:世界の治験レビュー Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, H1, 2014
出版日: 2014年05月21日 ページ情報: 英文 75 Pages
概要

当レポートでは、動脈瘤性くも膜下出血に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、主な先進国・新興国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤などの情報を盛り込んで、概略以下の構成でお届けします。

目次

イントロダクション

  • 動脈瘤性くも膜下出血
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の上位5ヶ国
    • 欧州の上位5ヶ国
    • 北米の主要国
    • 中東・アフリカの主要国
    • 中南米の主要国

G7諸国での治験件数:中枢神経系疾患の治験全体における動脈瘤性くも膜下出血の割合

G7諸国での治験件数:フェーズ(相)別

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:中枢神経系疾患の治験全体における動脈瘤性くも膜下出血の割合

E7諸国での治験件数:フェーズ(相)別

E7諸国での治験件数:進捗状況別

フェーズ(相)別の治験件数

  • 進行中の治験:フェーズ別

進捗状況別の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

  • 動脈瘤性くも膜下出血治療薬の治験に参加している上位企業

有望な薬剤

治験のプロファイル

  • 代表的企業の治験の概要
    • Actelion Ltd
    • Edge Therapeutics, Inc.
  • 代表的な研究機関・病院の治験の概要
    • Vanderbilt University
    • Chinese University of Hong Kong
    • Kuopio University Hospital
    • University of Cambridge
    • Charite - Universitatsmedizin Berlin
    • Utrecht University
    • Oslo University Hospital
    • Rigshospitalet
    • University of Miami
    • University of Calgary

5つの代表的な治験のプロファイル

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2152CTIDB

GlobalData's clinical trial report, "Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, H1, 2014" provides data on the Aneurysmal Subarachnoid Hemorrhage (SAH) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Aneurysmal Subarachnoid Hemorrhage (SAH). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Aneurysmal Subarachnoid Hemorrhage (SAH). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Aneurysmal Subarachnoid Hemorrhage (SAH)
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Aneurysmal Subarachnoid Hemorrhage (SAH) to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Aneurysmal Subarachnoid Hemorrhage (SAH) to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Aneurysmal Subarachnoid Hemorrhage (SAH)
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Actelion Ltd
      • Clinical Trial Overview of Actelion Ltd
      • Edge Therapeutics, Inc.
      • Clinical Trial Overview of Edge Therapeutics, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Vanderbilt University
      • Clinical Trial Overview of Vanderbilt University
      • Chinese University of Hong Kong
      • Clinical Trial Overview of Chinese University of Hong Kong
      • Kuopio University Hospital
      • Clinical Trial Overview of Kuopio University Hospital
      • University of Cambridge
      • Clinical Trial Overview of University of Cambridge
      • Charite - Universitatsmedizin Berlin
      • Clinical Trial Overview of Charite - Universitatsmedizin Berlin
      • Utrecht University
      • Clinical Trial Overview of Utrecht University
      • Oslo University Hospital
      • Clinical Trial Overview of Oslo University Hospital
      • Rigshospitalet
      • Clinical Trial Overview of Rigshospitalet
      • University of Miami
      • Clinical Trial Overview of University of Miami
      • University of Calgary
      • Clinical Trial Overview of University of Calgary
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials by Region, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Aneurysmal Subarachnoid Hemorrhage (SAH) to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Aneurysmal Subarachnoid Hemorrhage (SAH) to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Edge Therapeutics, Inc., 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kuopio University Hospital, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cambridge, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Utrecht University, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Oslo University Hospital, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Calgary, 2014*

List of Figures

  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Aneurysmal Subarachnoid Hemorrhage (SAH) to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Aneurysmal Subarachnoid Hemorrhage (SAH) to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top